Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001–12
Authors:
- 13 February 2017
- Vol. 112 (9) , 1558-1564
Abstract
Background and aims: The full burden of the opioid epidemic on US hospitals has not been described. We aimed to estimate how heroin (HOD) and prescription opioid (POD) overdose‐associated admissions, costs, outcomes and patient characteristics have changed from 2001 to 2012. Design: Retrospective cohort study of hospital admissions from the National Inpatient Sample (NIS). Setting: United States of America. Participants: Hospital admissions in patients aged 18 years or older admitted with a diagnosis of HOD or POD. The NIS sample included 94 492 438 admissions from 2001 to 2012. The final unweighted study sample included 138 610 admissions (POD: 122 147 and HOD: 16 463). Measurements: Primary outcomes were rates of admissions per 100 000 people using US Census Bureau annual estimates. Other outcomes included in‐patient mortality, hospital length‐of‐stay, cumulative and mean hospital costs and patient demographics. All analyses were weighted to provide national estimates. Findings: Between 2001 and 2012, an estimated 663 715 POD and HOD admissions occurred nation‐wide. HOD admissions increased 0.11 per 100 000 people per year [95% confidence interval (CI) = 0.04, 0.17], while POD admissions increased 1.25 per 100 000 people per year (95% CI = 1.15, 1.34). Total in‐patient costs increased by $4.1 million dollars per year (95% CI = 2.7, 5.5) for HOD admissions and by $46.0 million dollars per year (95% CI = 43.1, 48.9) for POD admissions, with an associated increase in hospitalization costs to more than $700 million annually. The adjusted odds of death in the POD group declined modestly per year [odds ratio (OR) = 0.98, 95% CI = 0.97, 0.99], with no difference in HOD mortality or length‐of‐stay. Patients with POD were older, more likely to be female and more likely to be white compared with HOD patients. Conclusions: Rates and costs of heroin and prescription opioid overdose related admissions in the United States increased substantially from 2001 to 2012. The rapid and ongoing rise in both numbers of hospitalizations and their costs suggests that the burden of POD may threaten the infrastructure and finances of US hospitals.Keywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism (F32AA024664)
This publication has 13 references indexed in Scilit:
- Opioid agonist treatment for pharmaceutical opioid dependent peopleCochrane Database of Systematic Reviews, 2016
- Hospitalizations Related To Opioid Abuse/Dependence And Associated Serious Infections Increased Sharply, 2002–12Health Affairs, 2016
- A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid AddictionJournal of Addiction Medicine, 2016
- Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014MMWR. Morbidity and Mortality Weekly Report, 2016
- Trends and characteristics of heroin overdoses in Wisconsin, 2003–2012Drug and Alcohol Dependence, 2015
- Drug-poisoning deaths involving heroin: United States, 2000-2013.2015
- Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.2014
- The Economic Burden of Opioid-Related Poisoning in the United StatesPain Medicine, 2013
- Intertwined Epidemics: National Demographic Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993–2009PLOS ONE, 2013
- Hospitalizations for Poisoning by Prescription Opioids, Sedatives, and TranquilizersAmerican Journal of Preventive Medicine, 2010